Compare Becton Dickinson and Co (BDX) vs iShares MSCI South Africa ETF (EZA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs iShares MSCI South Africa ETF — how do they compare? Becton Dickinson and Co trades at $149.95 (market cap $41.51B), while iShares MSCI South Africa ETF trades at $63.56. The key difference: Becton Dickinson and Co pays a 2.79% dividend while iShares MSCI South Africa ETF pays none. Which is the better fit depends on your goals.
| BDX | EZA | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $185.39 | $81.60 |
52-Week Low | $135.49 | $52.86 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
EZA trades at $62.76, down 1.66% in the last session. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators are neutral. The company has announced a future dividend of $1.43 per share scheduled for June 2026. Recent news highlights external factors like South Africa's fuel tax cuts, which may influence broader market sentiment.
The outlook remains cautious due to bearish technicals and limited fundamental data. The dividend provides a future income stream, but investors face risks from market volatility and macroeconomic uncertainties. Key catalysts include upcoming financial disclosures to assess profitability and valuation metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About iShares MSCI South Africa ETF
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →
